 |
Gaboxadol |
|---|---|
| Trade Name | |
| Orphan Indication | Fragile X syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2017-10-03 00:00:00 |
| Sponsor | Ovid Therapeutics;1460 Broadway;New York, New York, 10036 |
| |
Gaboxadol |
|---|---|
| Trade Name | |
| Orphan Indication | Fragile X syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2017-10-03 00:00:00 |
| Sponsor | Ovid Therapeutics;1460 Broadway;New York, New York, 10036 |